QPS Holdings, LLC’s Post

Exciting news in the field of cancer treatment! Recent studies presented at the ASCO meeting have shown promising early results for Malignant Melanoma and Pancreatic Cancer. Additionally, the University of Florida has announced a significant breakthrough in early studies of an mRNA vaccine for Glioblastoma, a severe brain tumor. The development of cancer vaccines, especially using mRNA technology, is on the horizon and poised to revolutionize treatment approaches. Stay tuned for more groundbreaking advancements in the fight against cancer! 🌟 #CancerResearch #MedicalAdvancements

Moderna and MSD Merck Sharp & Dohme A.G. collectively designed #mRNA4157/V940 as the world's first personalized mRNA cancer vaccine against Melanoma. The vaccine is currently in its Phase 3 trials (with and versus pembrolizumab, KEYTRUDA) and has been already tested by a 52-year old melanoma survivor from UK. The mRNA vaccine codes for upto 34 neoantigens unique for every patient based on the mutational signature of the tumor. This elicits a specific antitumor response by the immune system and developing adaptive immunity. This therapy opens up new avenues for #personalisedmedicine and #genetherapy in #oncology.

Are cancer vaccines ready for prime time ?? ➡️Interseting response on this insightfull article published after promising results on this field presented this week during the #AACR24🚀 🔎https://lnkd.in/etE23xff #Healthtech #Nextgeneration #Immuno #Oncology #Innovation #Cancerresearch

https://lnkd.in/eWkU87ap How personalized cancer vaccines could keep tumours from coming back The same mRNA technology that quickly brought the world a vaccine for COVID-19 is now showing promise as a bespoke therapy for cancer.

Vaccine Demonstrates Benefit in Delaying Cancer Relapse 🌟 A groundbreaking Phase I trial has shown that a lymph node-targeted cancer vaccine offers an 86 percent reduction in the risk of relapse or death in #pancreatic and #colorectal cancers. This is a significant step forward in preventing relapse of KRAS-mutated cancers in patients who have undergone surgery. ℹ The Phase II trial, set to commence later in 2024, will utilize a new formulation of the ELI-002 cancer vaccine, targeting additional KRAS mutations. The researchers presented preliminary data from the Phase I trial at the American Society of Clinical Oncology (ASCO) Annual Meeting and the American Association for Cancer Research (AACR) Special Conference on Pancreatic Cancer in 2023. The #vaccine showed a favourable #safety profile and may help many patients avoid relapse, potentially increasing survival rates. This promising development was supported by Elicio Therapeutics and underscores the potential of #immunotherapy in revolutionizing #cancertreatment. As we look forward to further advancements, let's celebrate this beacon of hope in the journey towards a world without cancer. 🌱💪🏼 #ElicioTherapeutics #cancerresearch #immunotherapy #hopeforthefuture #SymmetricTraining

Wow! Cancer treatment (the power of the combination of those two words!) Every since I studied some bio-engineering (two decades ago 😅) I found personalized medicine fascinating and promising. This text is about the world's first personalized mRNA vaccine for melanoma, showing 'gamechanging' potential. It's now in phase 3 trials and may dramatically reduce recurrence and pave the way for a permanent cancer cure. https://lnkd.in/dH7dy5iT

A new vaccine in early development shows promise in preventing the recurrence of 𝐜𝐨𝐥𝐨𝐫𝐞𝐜𝐭𝐚𝐥 𝐚𝐧𝐝 𝐩𝐚𝐧𝐜𝐫𝐞𝐚𝐭𝐢𝐜 𝐜𝐚𝐧𝐜𝐞𝐫𝐬, according to researchers at 𝐓𝐡𝐞 𝐔𝐧𝐢𝐯𝐞𝐫𝐬𝐢𝐭𝐲 𝐨𝐟 𝐓𝐞𝐱𝐚𝐬 𝐌𝐃 𝐀𝐧𝐝𝐞𝐫𝐬𝐨𝐧 𝐂𝐚𝐧𝐜𝐞𝐫 𝐂𝐞𝐧𝐭𝐞𝐫. 🩺🦠 Although still in the initial stages, a small study suggests the vaccine is safe and effective.💉💪 Colorectal and pancreatic cancers are among the deadliest forms, responsible for 𝐨𝐯𝐞𝐫 100,000 𝐝𝐞𝐚𝐭𝐡𝐬 in the U.S. in 2023. Given that they are among the most lethal and challenging to treat, this potential vaccine could be a significant 𝐛𝐫𝐞𝐚𝐤𝐭𝐡𝐫𝐨𝐮𝐠𝐡.🎯 Follow-up is ongoing, with a 𝐩𝐡𝐚𝐬𝐞 2 trial planned to further test ELI-002's safety and efficacy. If successful, this could be a game-changer in preventing cancer relapse. 🩹 #cancer #cancerresearch #pancreaticcancer #breakthroughs Read more here:

🔬 Breakthroughs in Cancer Diagnosis and Treatment The World Economic Forum highlights recent breakthroughs in cancer diagnosis and treatment that are revolutionizing patient care. From cutting-edge technologies to early detection methods, the future of cancer care looks brighter than ever. But behind every innovation is the crucial role of clinical trials. Clinical trials ensure that these groundbreaking therapies are tested for safety and effectiveness before reaching patients. By participating, patients contribute directly to advancing cancer treatment, helping to save lives and shape the future of healthcare. Read more about these exciting developments: https://buff.ly/4c0WvkZ #CancerResearch #ClinicalTrials #HealthcareInnovation #MedicalBreakthroughs #Oncology

Game-changer Cancer Jab Offers Hope of a Cure: The new jab, which is set to be tested on around 1,100 patients worldwide, is an individualised neoantigen therapy (INT) and is sometimes called a cancer jab. It is designed to trigger the immune system to fight back against the patient's specific type of cancer and tumour. Known as mRNA-4157 (V940), it targets tumour neoantigens, which are expressed by tumours and are individual to each patient. #cancer #oncology #melanoma #vaccine #skincancer #drugdiscovery #drugdelivery #medicalsciences #pharmaceutics #medicine #mrna

First Lung Cancer Vaccine Given to Patient in International Clinical Trial: The novel vaccine, BNT116, made by the German biotech company BioNTech, uses messenger RNA (mRNA) to present markers from the tumor to the patient’s immune system so it can recognize and fight the cancer cells carrying the tumor markers. The vaccine works selectively on cancer cells via the patient’s immune system, rather than, say, chemotherapy, which can be toxic to both cancerous and healthy cells. #cancer #oncology #vaccine #mrna #gene #drugdiscovery #drugdelivery #medicalsciences #pharmaceutics #medicine #drugdelivery #drugdevelopment